Literature DB >> 21982504

Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depression.

Helen L Fisher1, Sarah Cohen-Woods2, Georgina M Hosang2, Rudolf Uher2, Georgia Powell-Smith2, Robert Keers2, Maria Tropeano2, Ania Korszun3, Lisa Jones4, Ian Jones5, Mike Owen5, Nick Craddock5, Ian W Craig2, Anne E Farmer2, Peter McGuffin2.   

Abstract

BACKGROUND: An interaction between recent stressful life events (SLEs) and a serotonin transporter promoter polymorphism (5-HTTLPR) in depression has been inconsistently reported. Some of this variability may be due to a previous focus on sub-clinical depression, inclusion of individuals at the lower or upper ends of the age-span, or assumptions concerning the degree of dominance of the low expressing allele. Therefore, a large sample of patients with recurrent clinically diagnosed depression and controls screened for absence of depression was utilised to examine the moderating effect of each 5-HTTLPR genetic model on the association between SLEs and severe depressive episodes.
METHOD: A sample of 1236 recurrent unipolar depression cases and 598 age-matched, never psychiatrically ill controls completed the List of Threatening Experiences Questionnaire to assess the number of SLEs experienced in the 6 months prior to the most severe depressive episode (cases) or interview (controls). DNA extracted from blood or cheek swabs was genotyped for the short (s) and long (l) alleles of 5-HTTLPR.
RESULTS: A greater number of SLEs were reported by cases than controls and this held across all genotypic groups. There was no main effect of 5-HTTLPR on depression and no evidence of interaction between total SLEs and any of the 5-HTTLPR genetic models. The results were the same for men and women. LIMITATIONS: Utilisation of retrospective self-reported SLEs may have reduced the accuracy of the findings and the cross-sectional design prevents causal inference.
CONCLUSIONS: This study failed to find evidence of gene-environment interplay in recurrent clinical depression.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982504      PMCID: PMC3272366          DOI: 10.1016/j.jad.2011.09.016

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  31 in total

1.  The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation.

Authors:  Katja Karg; Margit Burmeister; Kerby Shedden; Srijan Sen
Journal:  Arch Gen Psychiatry       Date:  2011-01-03

2.  Association of the 5- HTTLPR genotype and unipolar depression: a meta-analysis.

Authors:  H Clarke; J Flint; A S Attwood; M R Munafò
Journal:  Psychol Med       Date:  2010-04-12       Impact factor: 7.723

3.  Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects.

Authors:  J Gelernter; H Kranzler; J F Cubells
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

4.  Adverse life event reporting and worst illness episodes in unipolar and bipolar affective disorders: measuring environmental risk for genetic research.

Authors:  G M Hosang; A Korszun; L Jones; I Jones; J M Gray; C M Gunasinghe; P McGuffin; A E Farmer
Journal:  Psychol Med       Date:  2010-02-05       Impact factor: 7.723

5.  Reliability and comparability of psychosis patients' retrospective reports of childhood abuse.

Authors:  Helen L Fisher; Thomas K Craig; Paul Fearon; Kevin Morgan; Paola Dazzan; Julia Lappin; Gerard Hutchinson; Gillian A Doody; Peter B Jones; Peter McGuffin; Robin M Murray; Julian Leff; Craig Morgan
Journal:  Schizophr Bull       Date:  2009-09-23       Impact factor: 9.306

6.  Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder.

Authors:  Sarah Cohen-Woods; Daria Gaysina; Nick Craddock; Anne Farmer; Joanna Gray; Cerisse Gunasinghe; Farzana Hoda; Lisa Jones; Jo Knight; Ania Korszun; Michael J Owen; Abram Sterne; Ian W Craig; Peter McGuffin
Journal:  Hum Mol Genet       Date:  2009-01-30       Impact factor: 6.150

7.  Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS).

Authors:  Darya Gaysina; Sarah Cohen-Woods; Philip C Chow; Livia Martucci; Alexandra Schosser; Harriet A Ball; Federica Tozzi; Julia Perry; Pierandrea Muglia; Ian W Craig; Peter McGuffin; Anne Farmer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

8.  Interaction between genetic polymorphisms and stressful life events in first episode depression.

Authors:  Jens Drachmann Bukh; Camilla Bock; Maj Vinberg; Thomas Werge; Ulrik Gether; Lars Vedel Kessing
Journal:  J Affect Disord       Date:  2009-03-31       Impact factor: 4.839

9.  Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results.

Authors:  Rudolf Uher; Avshalom Caspi; Renate Houts; Karen Sugden; Benjamin Williams; Richie Poulton; Terrie E Moffitt
Journal:  J Affect Disord       Date:  2011-03-24       Impact factor: 4.839

Review 10.  Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.

Authors:  Avshalom Caspi; Ahmad R Hariri; Andrew Holmes; Rudolf Uher; Terrie E Moffitt
Journal:  Am J Psychiatry       Date:  2010-03-15       Impact factor: 18.112

View more
  8 in total

1.  The interaction between stress and genetic factors in the etiopathogenesis of depression.

Authors:  Peter McGuffin; Margarita Rivera
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  Gene-environment interactions in common mental disorders: an update and strategy for a genome-wide search.

Authors:  Rudolf Uher
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-12-10       Impact factor: 4.328

3.  Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder.

Authors:  Helen L Fisher; Sarah Cohen-Woods; Georgina M Hosang; Ania Korszun; Mike Owen; Nick Craddock; Ian W Craig; Anne E Farmer; Peter McGuffin; Rudolf Uher
Journal:  J Affect Disord       Date:  2012-07-25       Impact factor: 4.839

Review 4.  Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Authors:  Deepika Suri; Cátia M Teixeira; Martha K Caffrey Cagliostro; Darshini Mahadevia; Mark S Ansorge
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

5.  Serotonin transporter gene (5-HTT) rs6354 polymorphism, job-related stress, and their interaction in burnout in healthcare workers in a Chinese hospital.

Authors:  Zeyuan Cao; Shuang Wu; Chao Wang; Li Wang; Jair C Soares; Shu-Chang He; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2018-09-04       Impact factor: 4.530

6.  Measuring Life Events and Their Association With Clinical Disorder: A Protocol for Development of an Online Approach.

Authors:  Ruth Spence; Amanda Bunn; Stephen Nunn; Georgina M Hosang; Lisa Kagan; Helen L Fisher; Matthew Taylor; Antonia Bifulco
Journal:  JMIR Res Protoc       Date:  2015-07-14

7.  5-HTTLPR and early childhood adversities moderate cognitive and emotional processing in adolescence.

Authors:  Matthew Owens; Ian M Goodyer; Paul Wilkinson; Anupam Bhardwaj; Rosemary Abbott; Tim Croudace; Valerie Dunn; Peter B Jones; Nicholas D Walsh; Maria Ban; Barbara J Sahakian
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

8.  Polygenic interactions with environmental adversity in the aetiology of major depressive disorder.

Authors:  N Mullins; R A Power; H L Fisher; K B Hanscombe; J Euesden; R Iniesta; D F Levinson; M M Weissman; J B Potash; J Shi; R Uher; S Cohen-Woods; M Rivera; L Jones; I Jones; N Craddock; M J Owen; A Korszun; I W Craig; A E Farmer; P McGuffin; G Breen; C M Lewis
Journal:  Psychol Med       Date:  2015-11-03       Impact factor: 7.723

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.